Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal‐bolus insulin therapy: A randomised controlled trial
Authors' conclusion
In conclusion, remote insulin dose adjustment based on interstitial glucose monitoring ameliorates glucose control in nursing home residents with T2D on basal-bolus insulin therapy.
Study context
- Population
- Nursing home residents with T2D on stable basal-bolus insulin therapy
- Participants
- 85 residents
- Comparison
- Telemedicine-assisted insulin titration based on continuous glucose monitoring (CGM) data vs standard care with capillary blood glucose monitoring
- Primary endpoint
- Change in TIR (70-180 mg/dL)
- Follow-up
- 12 weeks
Methodological detailsopen-label, 12-week
- Open-label
- 12-week
Primary result
As reported in the abstract
- Time in range (TIR) increased significantly in the intervention, but not in the control group
- Between Intervention and Control: P = 0.010
Secondary outcomes
| Outcome | P value |
|---|---|
| TBR | P = 0.007 |
| HbA1c | P = 0.028 |
| Mean insulin daily units | P = 0.002 |
Time below range (TBR)
- TBR reduced in the intervention arm and increased in the control arm
Haemoglobin A1c (HbA1c)
- HbA1c significantly decreased in the intervention group
Mean insulin daily units
- Mean insulin daily units significantly decreased in the intervention group
Safety
- No safety issues potentially related to the intervention were identified
Original publication
Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal‐bolus insulin therapy: A randomised controlled trial. Diabetes Obes Metab. Published 26 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →